Among the players of the adaptive response of cancer cells able to promote a resistant and aggressive phenotype, carbonic anhydrase IX (CAIX) recently has emerged as one of the most relevant drug targets. Indeed, CAIX targeting has received a lot of interest, and selective inhibitors are currently under clinical trials. Hypoxia has been identified as the master inductor of CAIX, but, to date, very few is known about the influence that another important characteristic of tumor microenvironment, i.e., extracellular acidosis, exerts on CAIX expression and activity. In the last decades, acidic microenvironment has been associated with aggressive tumor phenotype endowed with epithelial-to-mesenchymal transition (EMT) profile, high invasive and migratory ability, apoptosis, and drug resistance. We demonstrated that melanoma, breast, and colorectal cancer cells transiently and chronically exposed to acidified medium (pH 6.7 ± 0
Introduction
The acid microenvironment that characterizes most solid tumors results from the high glycolytic metabolism that distinguishes tumors from normal tissues. Besides Baerobic glycolysis^sustained by hypoxic cancer cells within tumor mass, cancer cells adopt the so called aerobic glycolysis, also known as Warburg effect, meaning that they use glycolysis even when O 2 is sufficient to support mitochondrial function [1] . The large excess of lactate and protons produced are extruded in the extracellular milieu by redundant families of transporters to maintain an intracellular pH compatible with cell survival and proliferation. As a result, cancers show a Breversed^pH gradient characterized by a higher intracellular pH than the extracellular one (> 7.4 vs 6.7-7.1, respectively), in contrast with normal tissues which usually are characterized by an intracellular pH lower than the extracellular pH. Such pH dysregulation is emerging as a further hallmark of cancer in view of its involvement in biological programs such as evasion to apoptosis, local invasion, and distant-site dissemination [2] . Also, a limited lymphatic vasculature alongside a high interstitial pressure contributes to the maintenance of an extracellular acidosis in cancer.
Among the several transporters involved in pH regulation within a tumor cell (i.e., monocarboxylate transporters, Na + / H + exchangers, the plasma membrane proton pump vacuolar ATPase, anion exchangers, and Na + /HCO 3 − co-transporters), carbonic anhydrase IX (CAIX) has emerged as one of the most important [3] . CAIX belongs to a family of zinc metalloenzymes that catalyze a rapid and reversible hydration of carbon dioxide to bicarbonate and protons [4] . At least 13 human CA isoenzymes exhibiting catalytic activity are distributed in various human organs, tissues, and subcellular compartments, playing an essential role in several cellular processes such as extracellular (pHe) and intracellular pH (pHi) regulation, secretion of electrolytes, respiration, and biosynthetic reactions that require CO 2 and HCO 3 − as substrates (e.g., lipogenesis, gluconeogenesis, ureagenesis) [5] [6] [7] . CAIX is the only transmembrane CA isoenzyme with an extracellular active site and an NH 2 -terminal proteoglycan-like region [8, 9] and, alongside with CAXII, is overexpressed in several types of tumors and correlated with malignancy [10] . Hypoxia represents the master inductor of CAIX expression through the tight regulation of HIF1-α [11, 12] , suggesting that hypoxic microenvironments induce the acquisition of tumor cell phenotypes expressing high levels of CAIX and contributing to the acidification of extracellular milieu. Importantly, CAIX shows an ideal catalytic activity at pH 6.49 [13] , a very close pH value to those found in most solid tumors [14] . Consequently, hypoxia and extracellular acidosis represent two peculiar components of tumor microenvironment tightly associated and able to influence each other in regulating several activities [15] [16] [17] [18] . What is highly significant is the finding that acidosis inhibits HIF-1α expression [19] [20] [21] and reconverts tumor cells from glycolysis to an oxidative metabolism [22] . Therefore, it is of importance to discriminate the individual contribution of hypoxia and acidosis, in order to establish new therapeutic approaches. To date, a lot of effort has been spent to elucidate the hypoxia-CAIX axis, but the correlation between extracellular acidosis and CAIX expression and activity is not completely clarified yet. Ihnatko et al. showed that CAIX level of human glioblastoma cells was stimulated by very low pH (6.4) via a transcriptional modulation that does not depend on hypoxia [20] , whereas Sørensen et al. demonstrated that CAIX expression of human uterine cervix and pharyngeal squamous carcinoma cells was inhibited under hypoxic conditions when pH was reduced to 6.3 [17, 18] . More recently, Matsubara et al., using a novel in vitro cell culture system, tested the complex interactions among extracellular pH, O 2 tension, and hydrostatic pressure on human osteosarcoma cells (HOCs) and found that the combination of acidosis and hypoxia under non-pressurized media promoted CAIX expression [23] .
In our study, we evaluated CAIX expression level either after a transient (24 h) or a chronic exposure (by at least 3 months) to an acidified medium (pH 6.7 ± 0.1) in different tumor types, such as human melanoma, breast, and colorectal carcinoma. We also tested whether the CAIX inhibitor FC16-670A has differential effects on acidosis-adapted cancer cells compared to those maintained in standard condition.
Materials and methods

Chemistry
Compound FC16-670A (SLC-0111) was synthesized according to the procedure reported in the literature. The experimental data are in agreement with previous reported data [24] [25] [26] .
Cell culture
Human melanoma cell line A375-M6 was isolated in our laboratory from lung metastasis of SCID bg/bg mice i.v. injected with A375 (ATCC); human breast carcinoma MCF7 cell line provided by ATCC, and human colorectal carcinoma cell line HCT116 was a kind gift of Dr. Matteo Lulli, Department of Clinical and Experimental Biomedical Sciences, University of Florence. A375-M6, MCF7, and HCT116 cell lines were maintained in DMEM 4.5 g/l glucose, 2 mM L-glutamine, and 10% FBS (Euroclone).
Acidification of culture medium and FC16-670A treatment
Chemical acidified medium was obtained by adding HCl 1 N in complete culture medium to reach pH 6.7 ± 0.1. pH value was monitored by using Orion pH meter 520A-1. pH was monitored for the first hour after medium acidification to check the maintenance of a pH value at 6.7, and then at the end point of each experiment. We observed that pH 6.7 was maintained stable up to 72 h. To mimic a transient or a chronic acidosis exposure, cells were grown in acidified medium for 24 h and at least 3 months, respectively. The CAIX inhibitor FC16-670A was administered together with acidified medium to assess its ability to prevent CAIX upregulation in acidic condition, while, to evaluate its cytotoxic effects, FC16-670A was given after a 24 h-exposure of cancer cells to acidified medium and leaved for up to 72 h.
Real-time RT-PCR
Total RNA was prepared using Tri Reagent (Sigma-Aldrich), agarose gel checked for integrity, and reverse transcribed with iScript cDNA Synthesis Kit (Bio-Rad) according to the manufacturer's instructions. Selected genes were evaluated by a real-time RT-PCR with 7500 Fast Real-Time PCR System (Applied Biosystems). Fold change was determined by the comparative Ct method using β2-microglobulin as the normalization gene. Amplification was performed with the PCR setting: 40 cycles of 95°C for 10 s and of 60°C for 30 s using SsoAdvanced™ Universal SYBR® Green Supermix (BioRad). Primer sequences (IDT, Tema Ricerca) are as follows: human β2-microglobulin, fw 5′-GCCGTGTGAACCAT GTGACT-3′, rv 3′-GCTTACATGTCTCGATCCCACTT-3′; human CAIX, fw 5′-CGGAAGAAAACAGTGCCTATGA-3′; rv 5′-CTTCCTCAGCGATTTCTTCCA-3′.
Flow cytometry
Cells were harvested by using Accutase (Euroclone), collected in flow cytometer tubes (2 × 10 5 cells/tube), and incubated 1 h at 4°C with anti-CAIX antibody (Merck Millipore). Cells were washed in PBS and incubated 1 h in the dark at 4°C with anti-mouse antibody conjugated with Alexa Fluor 488 (Invitrogen). Samples were washed in PBS and resuspended in 500 μl PBS to proceed with the analysis at BD FACSCanto (BD Biosciences). The flow cytometer was calibrated using cells incubated with secondary antibody only. For each sample, 1 × 10 4 events were analyzed.
Immunofluorescence
Cells were grown on glass coverslips in 6-well plates in standard or acidified medium for 24 h. For NF-κB nuclear localization, acidic stimuli and 1.5 μM parthenolide treatment lasted 6 h. Culture medium was removed, cells washed with PBS, fixed 30 min at 4°C with 3.7% paraformaldehyde and permeabilized for 15 min with PBS 0.1% Tryton X-100 at room temperature. Cells were then incubated 1 h at room temperature with blocking buffer (0.1% Triton X-100 and 5.5% horse serum PBS). After 1-h incubation with anti-CAIX antibody (Merck Millipore) or anti-NF-κB antibody (GeneTex) at room temperature, anti-mouse antibody conjugated with Alexa Fluor 488 (Invitrogen) or anti-rabbit antibody FITC-conjugated (Merck Millipore), respectively, was used for 45 min at room temperature in the dark. Subsequently, nuclei were stained with DAPI dye (Thermo Fisher Scientific) for 20 min at room temperature in the dark.
Cells were then dried, mounted onto glass slides, and examined with confocal microscopy using a Nikon Eclipse TE2000-U (Nikon). A single composite image was obtained by superimposition of 20 optical sections for each sample observed. The collected images were analyzed by ImageJ software. To calculate the correct fluorescence values, an outline around each cell was drawn and circularity, area, and mean fluorescence were measured, along with several adjacent background readings. The corrected total cellular fluorescence (CTCF) was calculated as the following: CTCF = integrated density − (cell area × fluorescence mean of background readings). To quantify instead NF-κB activation/inhibition, its nuclear localization was measured by using Manders' coefficients giving a mean of NF-κB and DAPI nuclear colocalization.
Western blot analysis
Cells were washed with ice-cold PBS containing 1 mM Na 4 VO 3 and lysed in 100 μl of cell RIPA lysis buffer (Merck Millipore) containing PMSF (Sigma-Aldrich), sodium orthovanadate (Sigma-Aldrich), and protease inhibitor cocktail (Calbiochem). 
Intracellular pH measurement
Cells (5 × 10 3 ) were plated in 96-well plate and treated with FC16-670A for 18 h in medium at pH 7.4 and 6.7. Cells were washed in PBS and incubated in the dark for 45 min at 37°C with 10 μM SNARF-4F 5-(and-6)-carboxylic acid, acetoxymethyl ester, and acetate (Thermo Fisher Scientific) diluted in DMEM without FBS. After three washes with PBS, 100 μl PBS per well was added to proceed with data acquisition. For each experimental setting, a standard curve was set, consisting of cell incubation with media at known pH with 10 μM nigericin. The microplate reader (Bio-Rad) was set as the following: 544 nm as excitation wavelength and 590 and 620 nm as absorbance wavelengths. Fluorescence emission ratio 620:590 nm was calculated and intracellular pH values interpolated by using the standard curve. Intracellular pH variation (ΔpHi) was calculated as the difference of pHi of FC16-670A-treated cells and pHi of control cells (ΔpHi = pHi treated − pHi control).
Results
Transient extracellular acidosis induces CAIX overexpression in A375-M6 melanoma cells
We have evaluated whether a differential CAIX expression occurs in A375-M6 melanoma cells grown for 24 h either in standard (pH 7.4) or in acidified medium (transient acidosis; pH 6.7). We observed that CAIX expression level deeply changed in response to different pH values. As shown in Fig. 1a , CAIX messenger RNA (mRNA) progressively increased with lowering pH. This data was confirmed by flow cytometer analysis of CAIX (Fig. 1b) , where a doubling protein expression level was observed in A375-M6 grown for 24 h at pH 6.7 with respect to control at pH 7.4. Immunofluorescence confocal analysis of CAIX and relative quantification chart confirmed the augmented CAIX expression in A375-M6 in response to a transient acidic microenvironment (Fig. 1c) as well as immunoblotting and relative quantification chart for CAIX (Fig. 1d) . Despite CAIX is known to strictly depend on HIF-1α signaling pathway, in our model of acidosis, we observed that CAIX increase is dependent instead on NF-κB signaling. Indeed, HIF-1α was not expressed by A375-M6 grown neither at pH 7.4 nor at pH 6.7 (Fig. 1e) , but by real-time RT-PCR analysis, we observed that the augmented CAIX expression at pH 6.7 was dramatically reverted by the NF-κB inhibitor parthenolide (Fig. 1f) , suggesting that NF-κB modulates CAIX expression in the absence of HIF-1α signaling, such as in the case of a transient extracellular acidosis. Parthenolide inhibitory effect on NF-κB has been measured as the efficacy to block the NF-κB nuclear localization after 6 h of acidic stimuli and quantified with Manders' coefficients by using ImageJ software, giving a measure of NF-κB and DAPI co-localization (Fig. 1g) .
The CAIX inhibitor FC16-670A affects A375-M6 melanoma cells adapted to transient acidosis
We have evaluated the effects of a novel CAIX inhibitor called FC16-670A, represented in Fig. 2a , in our model of transient acidosis. In Fig. 2b , we report CAIX mRNA expression level in A375-M6 treated or not for 24 h with 100 μM FC16-670A at pH 7.4 and 6.7. As shown in the graph, this compound, simultaneously given with the acidic medium, was able to prevent CAIX increase at pH 6.7, but had no effect when given to A375-M6 cells grown in standard condition. By flow cytometer analysis (Fig. 2c) , we observed that after 24-h treatment, CAIX protein level significantly decreased in acidified cells but not in those treated in standard medium, while 48 htreatment was able to dramatically downregulate CAIX expression in both standard and acidic conditions. By extending FC16-670A treatment to 72 h, we observed that this CAIX 
. Two-way ANOVA ***p < 0.001. g Representative pictures of immunofluorescence staining of NF-κB (green) in A375-M6 grown for 6 h at pH 7.4 and 6.7 in the presence or absence of 1.5 μM parthenolide (left). Nuclear DAPI staining in blue. Quantification chart of Manders' coefficients measuring NF-κB and DAPI co-localization (right). Two-way ANOVA **p < 0.01. Data shown in this figure refer to at least three independent experiments inhibitor selectively affected acidified melanoma cells in terms of cell viability. Indeed, as shown in Fig. 2d (upper  panel) , by Annexin V/PI assay, we observed a clear induction of cell death programs in A375-M6 treated with FC16-670A at pH 6.7; by contrast, no significant variation in cell viability was observed in A375-M6 treated with CAIX inhibitor at pH 7.4 up to 72 h. Similar results were obtained by direct cell counting in Trypan blue exclusion assay (Fig. 2d, lower panel) . Given the main role that CAIX exerts on pH homeostasis, we hypothesized that FC16-670A, by inhibiting CAIX, may induce cell death through a dysregulation of the delicate balance among the several mechanisms involved in the maintenance of an adequate intracellular pH. To verify that, we have evaluated if any intracellular pH variation occurs after FC16-670A treatment in A375-M6 at pH 7.4 and 6.7. As shown in Fig. 2e , intracellular pH was significantly increased in A375-M6 treated with FC16-670A in acidified medium, while no significant variation was observed when cells were treated at pH 7.4.
A375-M6 adapted to chronic acidosis overexpresses CAIX and undergoes cell death upon FC16-670A treatment
Since in tumor microenvironment extracellular acidosis could occur as a short-time insult or as a prolonged stressed condition, alongside with 24h-acidified melanoma cells, serving as a model of transient acidosis, we have generated chronically acidified A375-M6 to evaluate the effect of a prolonged acidosis condition. We observed an increase in CAIX mRNA (Fig. 3a) and protein ( Fig. 3b-d ) expression in chronically acidified A375-M6 compared to control cells grown at pH 7.4. By flow cytometer (Fig. 3b), immunofluorescence (Fig.  3c) , and immunoblotting (Fig. 3d) assays, we demonstrated a doubling expression level of CAIX in response to a chronically acidified microenvironment. We have observed that this augmented expression was reverted when cells were treated with parthenolide (Fig. 3e) , suggesting that NF-κB could act as the main regulator of CAIX in this model of chronic acidosis as well as in the model used for transient acidosis. Parthenolide inhibitory effect exerted on NF-κB in chronically acidified A375-M6 cells has been measured, by immunofluorescence analysis, as the efficacy to block the NF-κB nuclear localization and quantified with Manders' coefficients by using ImageJ software, giving a measure of NF-κB and DAPI co-localization (Fig. 3f) . We have also observed that chronically acidified A375-M6 was dramatically affected by FC16-670A treatment compared to not-acidified cells (Fig.  3g) . Annexin V/PI staining (upper panel) emerged that the cytotoxic effect that CAIX inhibitor selectively exerted on chronically acidified cells occurred already at 24 h and the percentage of apoptotic and necrotic cells progressively increased at 48 and 72 h, reaching around 80% cell death. Similar levels of cell death have been detected even with Trypan blue exclusion test (lower panel). This phenomenon could result from the intracellular pH increase taking place, upon FC16-670A treatment, in chronically acidified cells only (Fig. 3h) .
Transient extracellular acidosis induces CAIX overexpression in breast and colon cancer and selectively sensitizes acidic cancer cells to FC16-670A treatment
To verify whether the acidosis-induced CAIX overexpression is a peculiar trait of melanoma or a more general aspect of tumors, we extended our research to other histological tumor types, in particular breast and colorectal carcinomas, by using MCF7 and HCT116 cell lines, respectively. We demonstrated that a transient acidic microenvironment induced increased CAIX mRNA expression level in both MCF7 (Fig. 4a) and HCT116 (Fig. 5a) . By immunoblotting assay, we observed a significant increase in CAIX protein expression in response to transient acidosis in both MCF7 (Fig. 4b) and HCT116 (Fig.  5b) cell lines, also confirmed by immunofluorescence analysis (Figs. 4c and 5c, respectively) . Thus, by Annexin V/PI staining and Trypan blue exclusion test, we evaluated the effect of CAIX inhibition in these cell lines, by treating breast and colorectal carcinoma cells with 100 μM FC16-670A up to 72 h. CAIX inhibition significantly affected viability of acidified cancer cells without altering cell viability at pH 7.4 in MCF7 (Fig. 4d) as well as in HCT116 (Fig. 5d) cells. This cytotoxic effect may be related to the intracellular pH increase occurring upon FC16-670A treatment in acidified breast (Fig.  4e ) and colorectal carcinoma (Fig. 5e ) cells only.
Discussion
Since acidosis has been demonstrated in many types of human solid tumors and associated with cancer progression and disease outcome [27] [28] [29] , considerable effort has been made to elucidate the acidosis-adapted tumor phenotype. Despite several peculiar traits that tumor cells gain in response to different time exposure to a low pH have been described as possible markers of acidosis, the role and impact of CAIX in such tumor-acidic microenvironment still need to be clarified. It is known that acidosis may exist as a transient or chronic phenomenon, in view of the possibility that tumor cells might be exposed for a short or long period to acidosis. We believe that Fig. 2 Effects of CAIX inhibition in A375-M6 by FC16-670A inhibitor.
a Chemical structure of the CAIX inhibitor FC16-670A. b Real-time RT-PCR for CAIX detection after 24h-treatment with 100 μM FC16-670A in standard and acidic conditions. Two-way ANOVA **p < 0.01. c Flow cytometer analysis of CAIX expression in A375-M6 treated for 24 and 48 h with 100 μM FC16-670A in standard and acidic conditions. Representative plots are shown in the left panel and quantification chart in the right panel. Two-way ANOVA *p < 0.05; **p < 0.01; ***p < 0.001. d Quantification charts of death percentage by Annexin V/PI assay (upper) and Trypan blue exclusion test (lower) in A375-M6 treated for 24, 48, and 72 h with 100 μM FC16-670A at pH 7.4 and 6.7. Two-way ANOVA *p < 0.05; **p < 0.01; ***p < 0.001. e Quantification chart of intracellular pH variation (ΔpHi = pHi treatment − pHi control) in A375-M6 after 18h-treatment with 100 μM FC16-670A in standard (pHe 7.4) and acidic (pHe 6.7) conditions. t test *p < 0.05. Data shown in this figure refer to at least three independent experiments a chronic exposure to acidosis better mimics spontaneous tumors, but we do not exclude the possibility that tumor cells might be exposed to acidosis for a short period, considering the frequent variations in vasculature and lymphatic drainage. CAIX expression and activity has never been studied in chronic acidic tumor cells. In our study, we demonstrated that CAIX is subjected to a significant mRNA and protein expression increase in melanoma cells grown either transiently or chronically in an acidified medium (pH 6.7 ± 0.1). Similar results were obtained few years ago in human glioblastoma cells, observing a significant HIF-1α-independent CAIX upregulation after 24h-exposure to acidic medium [20] . Moreover, CAIX is known to confer chemotherapy and radiotherapy resistance to cancer cells [30] [31] [32] and stimulate the activation of PI3K/mTOR/p70S6K signal pathway, which is, in turn, involved in therapy resistance, whereas CAIX deficiency has been associated with migration-related gene inhibition (i.e., MMP-2 and MMP-9) [7, 33] . Of note, acidic microenvironment is associated with a high invasive phenotype endowed with drug resistance [34, 35] , and these observations re-enforce the liaison between tumor acidosis and CAIX.
Despite CAIX is considered as one of the major targets of hypoxia controlled by HIF-1α transcription factor, in our study, we evaluated the differential CAIX expression in acidic and non-acidic cancer cells under normoxic condition, to discriminate the single contribution of acidic microenvironment. Moreover, HIF-1α is repressed under extracellular acidosis as previously described [19] [20] [21] , and we confirmed that in our cellular model (Fig. 1e) . This finding is particularly consistent with the metabolic reprogramming that cancer cells undergo under acidosis, switching from glycolysis to oxidative phosphorylation [22, 36, 37] . In our cellular model, we observed that parthenolide, a NF-κB inhibitor, represses CAIX mRNA upregulation in acidified melanoma cells, suggesting that CAIX modulation in acidic microenvironment is driven by NF-κB, instead of HIF-1α. Consistent with that, in human tumor tissues, CAIX expression is rather diffuse and only partially overlapping with the distribution of HIF-1α, highlighting that CAIX can be expressed in non-hypoxic areas as well [38] . Moreover, very recently, a binding site for NF-κB has been found in the CAIX promoter and NF-κB associated with CAIX induction [39] .
Since CAIX represents a well-characterized enzyme involved in multiple crucial functions of tumor cells, several CAIX inhibitors have been developed to target cancer cells. We tested the effect of FC16-670A inhibitor on either transiently or chronically acidosis-adapted cancer cells. FC16-670A exerts its inhibition activity on CAIX by means of tight coordination to the zinc hydroxide, which is located deeper into the enzymatic catalytic cleft, and thus disrupts the carbon dioxide hydration catalytic cycle [24] [25] [26] . Moreover, FC16-670A prevents the CAIX overexpression by acidified cells, at both mRNA and protein level. Further, when treated with FC16-670A up to 72 h, a significant percentage of both transiently and chronically acidified melanoma cells undergo cell death compared to cells treated in standard medium. It seems that acidic cells represent a special subpopulation particularly addicted to CAIX activity. This is of clinical importance, because acidic tumor cells, besides expressing a malignant phen o ty p e c h a r a c t e r i z e d b y a n E M T p r o f i l e , h i g h metalloprotease-dependent invasiveness, and high metastatic potential, express a niche of cells with a high resistance to apoptosis, P-glycoprotein activity to escape pharmacological attack, and resistance to cytotoxicity of immune cells and radiotherapy [34, 35, 40] . In this scenario, CAIX targeting, by affecting this high-malignant acidic cancer subpopulation within tumor mass, could represent a possible therapeutic approach to reduce tumor relapse. FC16-670A-mediated cell death might be due to the rapid intracellular pH increase we observed by treating cancer cells under acidic condition. We hypothesized that CAIX inhibition may lead to HCO 3 − accumulation, that, in turn, can account for intracellular pH dysregulation and apoptosis initiation. By extending our study to breast and colorectal carcinoma cells, we observed that even in these cellular models, CAIX is overexpressed in response to transient extracellular acidosis, and FC16-670 treatment induces cell death programs in such acidic counterparts. One of the first studies on CAIX targeting demonstrated that the usage of a fluorescent sulfonamide CAIX inhibitor under hypoxia only may exert an in vivo tumor regression [41] . More recently, it has been demonstrated . t test *p < 0.05. d Quantification chart of death percentage by Annexin V/PI assay (upper) and Trypan blue exclusion test (lower) in MCF7 treated for 24, 48, and 72 h with 100 μM FC16-670A at pH 7.4 and 6.7. Two-way ANOVA *p < 0.05; **p < 0.01; ***p < 0.001. e Quantification chart of intracellular pH variation (ΔpHi = pHi treatment − pHi control) in MCF7 after 18-h treatment with 100 μM FC16-670A in standard (pHe 7.4) and acidic (pHe 6.7) conditions. t test **p < 0.01. Data shown in this figure refer to at least three independent experiments 24 , 48, and 72 h with 100 μM FC16-670A at pH 7.4 and 6.7. Twoway ANOVA *p < 0.05; **p < 0.01; ***p < 0.001. e Quantification chart of intracellular pH variation (ΔpHi = pHi treatment − pHi control) in HCT116 after 18-h treatment with 100 μM FC16-670A in standard (pHe 7.4) and acidic (pHe 6.7) conditions. t test *p < 0.05. Data shown in this figure refer to at least three independent experiments that an ureido-sulfonamide CAIX inhibitor was able to block breast cancer growth of both primary and metastatic lesions in in vivo model [24] . Further, it has been observed that by combining CAIX sulfonamide inhibitors with radiotherapy, a synergistic antitumor effect was obtained on colorectal carcinoma xenografts [30] .
To conclude, we demonstrated that, besides hypoxia, CAIX is strictly correlated with tumor acidic microenvironment and, more importantly, its activity is vital for the acidic population within tumor mass, that, in turn, is endowed with high-aggressive characteristics. Thus, CAIX inhibition could rise clinical interest since, besides hypoxic tumor regions, it would affect cancer cells exposed to either transient or chronic acidic microenvironment under normoxic condition.
